摘要:
The present invention provides BACE inhibitors of Formula (I); methods for their use and preparation, and intermediates useful for their preparation.
摘要:
The present invention provides BACE inhibitors of Formula (I); methods for their use and preparation, and intermediates useful for their preparation.
摘要:
Compounds of the formula (I) in which: R1 is (CH2)nY; n is 1 or 2; Y is NHSO2R2 or X1—W—X2—R3; X1 is O or NH; W is C═O, C═S, C═NH, or SO2; X2 is O or NH, provided that X1 and X2 are not both O; R2 is C1-10 alkyl; C2-10 alkenyl; C2-10 alkynyl; aryl; aryl-C1-10 alkyl; aryl-C2-10 alkenyl; aryl-C2-10alkynyl; C3-8 cycloalkyl or C3-8-cycloalkyl-C1-10 alkyl; and R3 is hydrogen, C1-10alkyl; C2-10 alkenyl; C2-10 alkynyl; aryl; aryl-C1-10 alkyl; aryl-C2-10 alkenyl; aryl-C2-10 alkynyl; C3-8 cycloalkyl; or C3-8-cycloalkyl-C1-10 alkyl; or a salt or ester thereof, modulate metabotropic glutamate receptor function and are useful in treating disorders of the central nervous system.
摘要翻译:式(I)的化合物,其中:R 1是(CH 2)n Y; n为1或2; Y是NHSO 2 R 2或X 1 -WX 2 - 3 - 3 ; X 1是O或NH; W是C-O,C-S,C-NH或SO 2。 X 2是O或NH,条件是X 1和X 2都不是O; R 2是C 1-10烷基; C 2-10链烯基; C 2-10炔基; 芳基; 芳基-C 1-10烷基; 芳基-C 2-10链烯基; 芳基-C 2-10炔基; C 3-8环烷基或C 3-8 - 环烷基-C 1-10烷基; R 3是氢,C 1-10烷基; C 2-10链烯基; C 2-10炔基; 芳基; 芳基-C 1-10烷基; 芳基-C 2-10链烯基; 芳基-C 2-10炔基; C 3-8环烷基; 或C 3-8 - 环烷基-C 1-10烷基; 或其盐或酯调节代谢型谷氨酸受体功能,并且可用于治疗中枢神经系统疾病。
摘要:
Compounds of formula (I) in which R1 is halo-C1-10 alkyl; halo-C2-10 alkenyl; or (CH2)nY in which n is 1 or 2 and Y is OH, CN, N3, OR3, SH, S(O)pR4, S(O)3H, NH2, NHR5, NR6R7, NHCOR8, NO2, CO2H, CONHR9, 1H-tetrazol-5-yl, 5-phenyltetrazol-2-yl or PO3H2; R3, R5, R6, R7, R8 and R9 are each selected independently from C1-4 alkyl, aryl and aryl-C1-4 alkyl; R4 is selected from C1-4 alkyl, aryl, aryl-C1-4 alkyl, and 1H-tetrazol-5-yl, carboxy-(1-4C)alkyl and 1H-tetrazol-5-yl-C1-4 alkyl; and p is 0, 1, 2 or 3; or a salt or ester thereof, provided that R1 is not methoxymethyl, modulate metabotropic glutamate receptor function and are useful in treating disorders of the central nervous system.
摘要翻译:其中R 1为卤代C 1-10烷基的式(I)化合物; 卤代-C2-10烯基; 或其中n为1或2且Y为OH,CN,N 3,OR 3,SH,S(O)p R 4,S(O)3 H,NH 2,NHR 5,NR 6 R 7,NHCOR 8,NO 2,CO 2 H,CONHR 9的(CH 2)n Y ,1H-四唑-5-基,5-苯基四唑-2-基或PO 3 H 2; R 3,R 5,R 6,R 7,R 8和R 9各自独立地选自C 1-4烷基,芳基和芳基-C 1-4烷基; R 4选自C 1-4烷基,芳基,芳基-C 1-4烷基和1H-四唑-5-基,羧基 - (1-4C)烷基和1H-四唑-5-基-C 1-4烷基; p为0,1,2或3; 或其盐或酯,条件是R1不是甲氧基甲基,调节代谢型谷氨酸受体功能,并且可用于治疗中枢神经系统的病症。
摘要:
The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to Syndrome X as well as cardiovascular diseases.